Suicide with moclobemide and perazine

International Journal of Legal Medicine

Volumn 111, Issue 4, 1998, Pages 196-198

  Musshoff, F ^a   Varchmin Schultheiss, K ^a   Madea, B ^a  

^a Institute of Legal Medicine   (Germany)

Author keywords

Moclobemide; Perazine; Suicide

Indexed keywords

MOCLOBEMIDE; PERAZINE;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; CAUSE OF DEATH; DEPRESSION; DRUG DETERMINATION; DRUG INTOXICATION; DRUG OVERDOSE; FEMALE; HUMAN; PRIORITY JOURNAL; SUICIDE;

EID: 0031860166     PISSN: 09379827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004140050149     Document Type: Article

References (29)

1. Benazzi F (1996) Serotonin syndrome with moclobemide-fluoxetine combination (letter). Pharmacopsychiatry 29:162
2. Breyer U, Villumsen K (1976) Measurement of plasma levels of tricyclic psychoactive drugs and their metabolites by UV reflectance photometry of thin layer chromatography. Eur J Clin Pharmacol 9:457-465
3. Brodribb TR, Downey M, Gilbar PJ (1993) Efficacy and adverse effects of moclobemide. Lancet 343:474-476
4. Camaris C, Little D (1997) A fatality due to moclobemide. J Forensic Sci 42:954-955
5. Da Prada M, Kettler R, Keller HH, Burkard WP, Muggli-Maniglio D, Haefely WE (1989) Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. J Pharmacol Exp Ther 248:400-114
6. Enss H, Hartmann K, Hippius H, Richter HE (1958) Klinische Erfahrungen mit einem neuen Piperazin-Derivat des Phenothiazins in der Neuropsychiatrie. Arch Psychiatr Nervenkr 197: 534-550
7. Francois B, Marquet P, Desachy A, Roustan J, Lachatre G, Gastinne H (1997) Serotonin syndrome due to an overdose of moclobemide and clomipramine. A potentially life-threatening association. Intensive Care Med 23:122-124
8. Fulton B, Benfield P (1996) Moclobemide. An update of its pharmacological properties and therapeutic use. Drugs 52:450-474
9. Gaillard Y, Pepin G (1997) Moclobemide fatalities: report of two cases and analytical determinations by GC-MS and HPLC-PDA after solid-phase extraction. Forensic Sci Int 87:239-248
10. Geschke R, Körner J, Eggers H (1987) Determination of the new monoamine oxidase inhibitor moclobemide and three of its metabolites in biological fluids by high-performance liquid chromatography. J Chromatogr 420:111-120
11. Gillman PK (1995) Possible serotonin syndrome with moclobemide and pethidine (letter). Med J Aust 162:554
12. Grohmann R, Koch R, Schmidt LG (1990) Extrapyramidal symptoms in neuroleptic recipients. Agents Actions Suppl 29: 71-82
13. Hackett LP, Joyce DA, Hall RW, Dusci LJ, Ilett KF (1993) Disposition and clinical effects of moclobemide and three of its metabolites following overdose. Drug Invest 5:281-284
14. Heinze G, Sanchez A (1986) Overdose with moclobemide. J Clin Psychiatry 47(8):438
15. Hernandez AF, Montero MN, Pla A, Villanueva E (1995) Fatal moclobemide overdose or death caused by serotonin syndrome? J Forensic Sci 40:128-130
16. Hetzel W (1992) Safety of moclobemide taken in overdose for attempted suicide. Psychopharmacology 106:S127-S129
17. Hilton S, Jaber B, Ruch R (1995) Moclobemide safety: monitoring a newly developed product in the 1990s J Clin Psychopharmacol 15:76S-83S
18. Iwersen S, Schmoldt A (1995) Überdosierungen von Moclobemid - Nachweis eines neuen Antidepressivums und seiner Metaboliten. Toxichem + Krimtech 62 (1):56-61
19. Iwersen S, Schmoldt A (1996) Three suicide attempts with moclobemide. J Toxicol Clin Toxicol 34:223-225
20. Jauch R, Griesser E, Oesterhelt G, Arnold W, Meister W, Ziegler WH, Guentert TW (1990) Biotransformation of moclobemide in humans. Acta Psychiatr Scand Suppl 360:87-90
21. Kuisma MJ (1995) Fatal serotonin syndrome with trismus (letter). Ann Emerg Med 26:108
22. McIntyre IM, King CV, Staikos V, Gall J, Drummer OH (1997) A fatality involving moclobemide, sertraline, and pimozide. J Forensic Sci 42:951-953
23. Myrenfors PG, Eriksson T, Sandsted CS, Sjöberg G (1993) Moclobemide overdose. J Intern Med 233:113-115
24. Neuvonen PJ, Pohjola-Sintonen S, Tacke U, Vuori E (1993) Five fatal cases of serotonin syndrome after moclobemidecitalopram ormoclobemide-clomipramine overdoses (letter). Lancet 342:1419
25. Pietzcker A, Poppenberg A, Schley J, Müller-Oerlinghausen B (1981) Outcome and risks of ultra-long-term treatment with an oral neuroleptic drug. Relationship between perazine serum levels and clinical variables in schizophrenic outpatients. Arch Psychiatr Nervenkr 229:315-329
26. Power BM, Pinder M, Hackett LP, Ilett KF (1995) Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine. Anaesth Intensive Care 23:499-502
27. Spigset O, Mjörndal T (1993) Serotonin syndrome caused by a moclobemide-clomipramine interaction. BMJ 3:248
28. Sternbach H (1991) The serotonin syndrome. Am J Psychiatry 148:705-713
29. Vine R, Norman TR, Burrows GD (1988) A case of moclobemide overdose. Int Clin Psychopharmacol 3:325-326